Current Considerations in the Treatment of Generalized Anxiety Disorder

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.2, 2009-01, pp. : 103-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Psychiatrists' treatment preferences for generalized anxiety disorder

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 33, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non-Antidepressant Treatment of Generalized Anxiety Disorder

Current Clinical Pharmacology, Vol. 10, Iss. 2, 2015-01 ,pp. : 86-96

Bentham Science Publishers

Access to resources Recommend Favorite

Social Anxiety Disorder: Current Treatment Recommendations

By Muller Jacqueline E. Koen Liezl Seedat Soraya Stein Dan J.

CNS Drugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 377-391

Adis International

Access to resources Recommend Favorite

Duloxetine: A Review of its Use in the Treatment of Generalized Anxiety Disorder

By Carter Natalie J. McCormack Paul L.

CNS Drugs, Vol. 23, Iss. 6, 2009-05 ,pp. : 523-541

Adis International

Access to resources Recommend Favorite

Antidepressants are the main options for the long-term pharmacological treatment of generalized anxiety disorder

Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite